AI assistant
Sending…
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012
Apr 25, 2012
29864_dirs_2012-04-25_f5cfe837-9121-4e45-8d15-8adc90c8d55c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2011-12-31
Reporting Person: BOGER JOSHUA S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-10-25 | Common Stock | W | 1946 | $0.00 | Acquired | 733395 | Direct |
Footnotes
F1: The estate of a relative distributed these shares to Dr. Boger
More from VERTEX PHARMACEUTICALS INC / MA
Major Shareholding Notification
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13